Pharmacogenomics is another area benefiting from genetic research. This field focuses on how genetic variations influence responses to medications. Customizing drug treatments based on genetic profiles enhances their effectiveness and reduces adverse reactions.
Research institutions and healthcare providers in Canada are contributing to the advancement of genetic medicine. Collaborative efforts in genomic research support the development of innovative treatments for complex diseases such as cancer and neurological disorders.
As genetic technologies become more accessible, personalized medicine is expected to play a larger role in healthcare. Ethical considerations, data privacy, and regulatory oversight remain key factors in integrating genetic insights into medical practice.
